These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 8253955
1. Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology. Gunzer F, Karch H. J Clin Microbiol; 1993 Oct; 31(10):2604-10. PubMed ID: 8253955 [Abstract] [Full Text] [Related]
3. Expression and purification of Shiga-like toxin II B subunits. Acheson DW, De Breucker SA, Jacewicz M, Lincicome LL, Donohue-Rolfe A, Kane AV, Keusch GT. Infect Immun; 1995 Jan; 63(1):301-8. PubMed ID: 7806370 [Abstract] [Full Text] [Related]
4. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. Rüssmann H, Schmidt H, Heesemann J, Caprioli A, Karch H. J Med Microbiol; 1994 May; 40(5):338-43. PubMed ID: 7909850 [Abstract] [Full Text] [Related]
5. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli. Sung LM, Jackson MP, O'Brien AD, Holmes RK. J Bacteriol; 1990 Nov; 172(11):6386-95. PubMed ID: 2228965 [Abstract] [Full Text] [Related]
7. Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279. Meyer T, Karch H, Hacker J, Bocklage H, Heesemann J. Zentralbl Bakteriol; 1992 Jan; 276(2):176-88. PubMed ID: 1559006 [Abstract] [Full Text] [Related]
8. Humoral immune responses to Shiga-like toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects. Greatorex JS, Thorne GM. J Clin Microbiol; 1994 May; 32(5):1172-8. PubMed ID: 8051241 [Abstract] [Full Text] [Related]
9. Shiga-like toxin II-related cytotoxins in Citrobacter freundii strains from humans and beef samples. Schmidt H, Montag M, Bockemühl J, Heesemann J, Karch H. Infect Immun; 1993 Feb; 61(2):534-43. PubMed ID: 8423084 [Abstract] [Full Text] [Related]
10. Highly conserved B-subunit genes of Shiga-like toxin II variants found in Escherichia coli O157 strains. Rüssmann H, Schmidt H, Caprioli A, Karch H. FEMS Microbiol Lett; 1994 May 15; 118(3):335-40. PubMed ID: 8020756 [Abstract] [Full Text] [Related]
11. Clinical and genetic aspects of Shiga-like toxin production in traditional enteropathogenic Escherichia coli. Bitzan M, Karch H, Maas MG, Meyer T, Rüssmann H, Aleksić S, Bockemühl J. Zentralbl Bakteriol; 1991 Jan 15; 274(4):496-506. PubMed ID: 1863318 [Abstract] [Full Text] [Related]
12. Regulation of the Shiga-like toxin II operon in Escherichia coli. Mühldorfer I, Hacker J, Keusch GT, Acheson DW, Tschäpe H, Kane AV, Ritter A, Olschläger T, Donohue-Rolfe A. Infect Immun; 1996 Feb 15; 64(2):495-502. PubMed ID: 8550198 [Abstract] [Full Text] [Related]
13. Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies. Downes FP, Barrett TJ, Green JH, Aloisio CH, Spika JS, Strockbine NA, Wachsmuth IK. Infect Immun; 1988 Aug 15; 56(8):1926-33. PubMed ID: 3294179 [Abstract] [Full Text] [Related]
14. Clonal relatedness of Shiga-like toxin-producing Escherichia coli O101 strains of human and porcine origin. Franke S, Harmsen D, Caprioli A, Pierard D, Wieler LH, Karch H. J Clin Microbiol; 1995 Dec 15; 33(12):3174-8. PubMed ID: 8586696 [Abstract] [Full Text] [Related]
15. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons. Paton AW, Bourne AJ, Manning PA, Paton JC. Infect Immun; 1995 Jul 15; 63(7):2450-8. PubMed ID: 7790056 [Abstract] [Full Text] [Related]
16. Two copies of Shiga-like toxin II-related genes common in enterohemorrhagic Escherichia coli strains are responsible for the antigenic heterogeneity of the O157:H- strain E32511. Schmitt CK, McKee ML, O'Brien AD. Infect Immun; 1991 Mar 15; 59(3):1065-73. PubMed ID: 1997410 [Abstract] [Full Text] [Related]
17. Neutralizing antibodies against Shiga-like toxins from Escherichia coli in colostra and sera of cattle. Pirro F, Wieler LH, Failing K, Bauerfeind R, Baljer G. Vet Microbiol; 1995 Feb 15; 43(2-3):131-41. PubMed ID: 7740752 [Abstract] [Full Text] [Related]
18. Comparison of Shiga-like toxin I B-subunit expression and localization in Escherichia coli and Vibrio cholerae by using trc or iron-regulated promoter systems. Acheson DW, Calderwood SB, Boyko SA, Lincicome LL, Kane AV, Donohue-Rolfe A, Keusch GT. Infect Immun; 1993 Mar 15; 61(3):1098-104. PubMed ID: 8432592 [Abstract] [Full Text] [Related]
19. Analysis of the enterohemorrhagic Escherichia coli O157 DNA region containing lambdoid phage gene p and Shiga-like toxin structural genes. Datz M, Janetzki-Mittmann C, Franke S, Gunzer F, Schmidt H, Karch H. Appl Environ Microbiol; 1996 Mar 15; 62(3):791-7. PubMed ID: 8975608 [Abstract] [Full Text] [Related]
20. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality. Lindgren SW, Samuel JE, Schmitt CK, O'Brien AD. Infect Immun; 1994 Feb 15; 62(2):623-31. PubMed ID: 8300218 [Abstract] [Full Text] [Related] Page: [Next] [New Search]